Clinical Trials Browser

Hodgkin Disease

Leiomyosarcoma

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma

Triple Negative Breast Neoplasms

Sinonasal Tumors

Unresectable Sinonasal Tumors

Hepatocellular Carcinoma Resectable

Breast Neoplasms

Liver, Cancer of, Primary Resectable

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Ovarian Neoplasms

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Hepatocellular

Triple Negative Breast Neoplasms

Burkitt Lymphoma

Lymphoma, T-Cell, Peripheral

Multiple Myeloma

The Neoadjuvant Therapy

Chemotherapy-induced Neutropenia

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Breast Neoplasms

Stomach Neoplasms

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Multiple Myeloma

Hodgkin Disease

Breast Neoplasms

Carcinoma, Hepatocellular

Lymphoma, Large B-Cell, Diffuse

Breast Neoplasms

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Neoplasms, Experimental

Osteosarcoma

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Lymphoma, T-Cell, Peripheral

Breast Neoplasms

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

Breast Neoplasms

Clinical Trials

BV-AVD-R Treatment Children Hodgkin's Lymphoma

FIBROSARC US

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

FB-12

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

TONIC

ZR2-CHOP

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

SBRT or TACE for Advanced HCC

A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

Biomarker Guided Treatment in DLBCL

HD16

The Effect of Metformin on Breast Cancer Patients

Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

DR-CHOP

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

PDD vs PAD to Treat Initially Diagnosed MM

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

(Optimist)

MBC1

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Effectiveness of Drug Eluting TACE in Primary HCC

GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Trial of DA-EPOCH Regimen for NHL With HLH

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Timing of Surgery in Nonmetastatic Osteosarcoma of the Pelvis and Sacrum

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NeoChAI

CHEMO-T

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy